glp-1 agonists tirzepatide use tripled among non-diabetics, reaching $5.8B in 2022 GLP-1 Agonists in Perimenopause: Unique
Description
A new blockbuster class of therapeutics, glucagon-like peptide 1 (GLP-1) analogs (eg, semaglutide), shows promise at curbing both diseases
Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, movement, mindset, and the lasting habits that can help keep weight off for goodPRINCETON, N.J., June 24, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company trusted by millions, today announced the launch of its free GLP-1 Companion program, now available at no cost to anyone taking a GLP-1 medication, regardless of provider
Learn about Farxiga side effects, from common ones like increased urination to more serious
Another systematic review of randomized trials found that muscle-related indices often exceeded the usual benchmark of about 25% of weight loss coming from fat-free mass
Discover how GLP-1 medications are reshaping the food and beverage industry, driving demand for smaller-portion, nutrient-dense products
